(Q59284846)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17319919%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

title

Eslicarbazepine acetate: a double-blind, add-on, placebo-controlled exploratory trial in adult patients with partial-onset seizures (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17319919%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17319919%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Patrício Soares-da-Silva

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17319919%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Christian Elger

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17319919%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Meir Bialer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17319919%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Joana Maia

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17319919%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Joyce A Cramer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17319919%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

21 February 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17319919%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17319919%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17319919%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17319919%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

497-504

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17319919%20AND%20SRC:MED&resulttype=core&format=json

Safety, tolerability and pharmacokinetic profile of BIA 2-093, a novel putative antiepileptic agent, during first administration to humans

26 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00984.X

Safety, tolerability, and pharmacokinetic profile of BIA 2-093, a novel putative antiepileptic, in a rising multiple-dose study in young healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00984.X

Single-dose and steady-state pharmacokinetics of eslicarbazepine acetate (BIA 2-093) in healthy elderly and young subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00984.X

Inhibition of glutamate release by BIA 2-093 and BIA 2-024, two novel derivatives of carbamazepine, due to blockade of sodium but not calcium channels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00984.X

Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, BIA 2-093, and BIA 2-024.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00984.X

Anticonvulsant and sodium channel-blocking properties of novel 10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00984.X

Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00984.X

Interaction of the novel anticonvulsant, BIA 2-093, with voltage-gated sodium channels: comparison with carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00984.X

Magnitude of the placebo effect in randomized trials of antiepileptic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00984.X

Eslicarbazepine acetate (BIA 2-093) : relative bioavailability and bioequivalence of 50 mg/mL oral suspension and 200mg and 800mg tablet formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00984.X

Metabolism of two new antiepileptic drugs and their principal metabolites S(+)- and R(-)-10,11-dihydro-10-hydroxy carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00984.X

Carbamazepine-induced hyponatremia: assessment of risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00984.X

Effect of food on the pharmacokinetic profile of eslicarbazepine acetate (BIA 2-093).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00984.X

Oxcarbazepine for Treatment of Partial Epilepsy: A Review and Recommendations for Clinical Use

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00984.X

10.1111/J.1528-1167.2007.00984.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17319919%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference